HCG — Healthcare Global Enterprises Share Price
0.000.00%
Last trade - 00:00- IN₹77.51bn
- IN₹90.68bn
- IN₹19.08bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 72.72 | ||
| PEG Ratio (f) | 1.39 | ||
| EPS Growth (f) | 109.92% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.04 | ||
| Price to Tang. Book | 12.77 | ||
| Price to Free Cashflow | 84.35 | ||
| Price to Sales | 3.66 | ||
| EV to EBITDA | 24.41 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.79% | ||
| Return on Equity | 6.78% | ||
| Operating Margin | 8.17% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 10,923.4 | 10,091.85 | 13,947.78 | 16,914.14 | 19,078.71 | 22,326.77 | 25,801.4 | 14.35% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | +52.07 | +12.25 | +109.92 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
HealthCare Global Enterprises Limited is an India-based cancer care provider. The Company is a provider of specialty healthcare focused on cancer and fertility. The Company operates cancer care network in India in terms of the total number of private cancer treatment centers under the brand HCG. The Company also provide fertility treatment under its Milann brand. Its Milann fertility centers provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation; and follow a multidisciplinary and technology focused approach to diagnosis and treatment. The Triesta brand, it offers oncology diagnostics, biomarker and translational research, and laboratory services. The Company also operates comprehensive cancer care center in Indore, Madhya Pradesh. The Company is also engaged in radiation business in Indore, Madhya Pradesh.
Directors
- B. Ajaikumar CHM (69)
- Srinivasa Raghavan CFO (55)
- Madhavi Kanumoory CIO (49)
- Sunu Manuel CCO
- Meghraj Gore EDR
- Rani Bhat OTH (46)
- Bharat Gadhavi OTH (56)
- Anant Kittur OTH (47)
- Gangadhara Ganapati NED (49)
- Amit Varma NED (52)
- Abhay Havaldar IND (59)
- Pradip Kanakia NID
- Bhushani Kumar NID
- Suresh Senapaty NID (62)
- Jeyandran Venugopal NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 12th, 1998
- Public Since
- March 30th, 2016
- No. of Shareholders
- 27,195
- No. of Employees
- 6,150
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 139,415,370
- Address
- Tower Block, Unity Building Complex,, BANGALORE, 560027
- Web
- https://hcgel.com/
- Phone
- +91 8046607700
- Contact
- Sunu Manuel
- Auditors
- BSR & Co. LLP
Upcoming Events for HCG
Q1 2026 Healthcare Global Enterprises Ltd Earnings Release
Healthcare Global Enterprises Ltd Annual Shareholders Meeting
Similar to HCG
Aatmaj Healthcare
National Stock Exchange of India
Apollo Hospitals Enterprise
National Stock Exchange of India
Artemis Medicare Services
National Stock Exchange of India
Aster DM Healthcare
National Stock Exchange of India
Chandan Healthcare
National Stock Exchange of India
FAQ
What is the Healthcare Global Enterprises share price?
As of Today at 21:03 UTC, shares in Healthcare Global Enterprises are trading at IN₹558.70. This share price information is delayed by 15 minutes.
How has the Healthcare Global Enterprises share price performed this year?
Shares in Healthcare Global Enterprises last closed at IN₹558.70 and the price had moved by +56.37% over the past 365 days. In terms of relative price strength the Healthcare Global Enterprises share price has outperformed the S&P BSE 100 Index by +47.3% over the past year.
What are the analyst and broker recommendations for Healthcare Global Enterprises?
The overall consensus recommendation for Healthcare Global Enterprises is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Healthcare Global Enterprises dividend yield?
Healthcare Global Enterprises does not currently pay a dividend.
Does Healthcare Global Enterprises pay a dividend?
Healthcare Global Enterprises does not currently pay a dividend.
When does Healthcare Global Enterprises next pay dividends?
Healthcare Global Enterprises does not currently pay a dividend.
How do I buy Healthcare Global Enterprises shares?
To buy shares in Healthcare Global Enterprises you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Healthcare Global Enterprises?
As of the previous close price of IN₹558.70, shares in Healthcare Global Enterprises had a market capitalisation of IN₹77.51bn.
Where are Healthcare Global Enterprises shares listed?
Here are the trading details for Healthcare Global Enterprises:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: HCG
What kind of share is Healthcare Global Enterprises?
Based on an overall assessment of its quality, value and momentum Healthcare Global Enterprises is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Healthcare Global Enterprises share price forecast for 2025?
The analyst consensus target price for shares in Healthcare Global Enterprises is IN₹559.25. That is 0.1% above the last closing price of IN₹558.70.
Analysts covering Healthcare Global Enterprises currently have a consensus Earnings Per Share (EPS) forecast of IN₹3.66 for the next financial year.
Find out moreWhat is the trend in the Healthcare Global Enterprises share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Healthcare Global Enterprises. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +33.25%.
As of the last closing price of IN₹558.70, shares in Healthcare Global Enterprises were trading +21.25% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Healthcare Global Enterprises PE Ratio?
The Healthcare Global Enterprises PE ratio based on its reported earnings over the past 12 months is 72.72. The shares last closed at IN₹558.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Healthcare Global Enterprises?
Healthcare Global Enterprises' management team is headed by:
- B. Ajaikumar - CHM
- Srinivasa Raghavan - CFO
- Madhavi Kanumoory - CIO
- Sunu Manuel - CCO
- Meghraj Gore - EDR
- Rani Bhat - OTH
- Bharat Gadhavi - OTH
- Anant Kittur - OTH
- Gangadhara Ganapati - NED
- Amit Varma - NED
- Abhay Havaldar - IND
- Pradip Kanakia - NID
- Bhushani Kumar - NID
- Suresh Senapaty - NID
- Jeyandran Venugopal - NID